Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 10, 2015

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Hepatitis C Virus

Interventions

DRUG

Paritaprevir

DRUG

Ritonavir

DRUG

Dasabuvir

DRUG

Ombitasvir

DRUG

Ribavirin

In genotype 1b individuals without cirrhosis, treatment will NOT include ribavirin.

All Listed Sponsors

collaborator

Provincial Correction Centre (PEI)

UNKNOWN

lead

Nova Scotia Health Authority

OTHER